Mark G. Foletta, Director at DEXCOM INC (DXCM), sold 1,867 shares at $218.39 ($407K) on 2020-01-03, disclosed to the SEC on 2020-01-07.
Open-market sale of $407k DXCM by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $217.61 | 528 | $115K | 28.2% |
| 2 | $217.61 | 528 | $115K | 28.2% |
| 3 | $218.39 | 339 | $74K | 18.2% |
| 4 | $218.39 | 339 | $74K | 18.2% |
| 5 | $218.94 | 133 | $29K | 7.2% |
| Total | $217.99 avg | 1,867 |
| $407K |
| 100% |
| Filing → |
| DXCM | SELL | 2026-06-17 | $297K | — | Filing → |
| DXCM | SELL | 2025-08-18 | $430K | — | Filing → |
| DXCM | SELL | 2025-07-17 | $468K | — | Filing → |